US IPO Pipeline SEC S-1 Filings — July 10, 2026

10-07-2026

Smith Micro Software, Inc. filed an S-1 registration statement on July 10, 2026, covering the resale of up to 487,349 shares of common stock by selling stockholders upon exercise of warrants issued in a June 2026 warrant inducement transaction. The company will not receive any proceeds from the resale, but may receive up to approximately $1.85 million if all warrants are exercised for cash. As of March 31, 2026, the company had a net tangible book value of $1.0 million ($0.20 per share), which would have increased to $0.51 per share if the June inducement proceeds and shares were included, indicating significant dilution risk for new investors.

• · The selling stockholders include Iroquois Master Fund Ltd., Iroquois Capital Investment Group LLC, John P. Gutfreund, Newtown Road 130 Holdings LLC, Unterberg Legacy Capital, LLC, and Anson Investments Master Fund LP.
• · The warrants contain a beneficial ownership limitation of 4.99% (or up to 9.99% upon election) that may prevent full exercise.
• · The company does not anticipate paying cash dividends in the foreseeable future.
• · The offering will not change the net tangible book value per share, but purchasers from selling stockholders may experience dilution.
• · The company has not determined the offering price or the amount of net proceeds to be used for specific purposes.

10-07-2026

Avalanche Treasury Corp (formerly Mountain Lake Acquisition Corp) filed an S-1 registration statement for its IPO, which involves a business combination with Avalanche Treasury Company LLC. The combined entity holds digital assets including Avalanche tokens, and has engaged in private placements with Astral Horizon LP and Dragonfly Digital Management LLC. While the filing reflects substantial digital asset holdings and investor commitments, the company reported a net loss of $2,000,000 on revenue of $0 for the three months ended March 31, 2026, highlighting pre-revenue status and significant operating expenses.

• · The filing is a business combination via a reverse merger between Mountain Lake Acquisition Corp (SPAC) and Avalanche Treasury Company LLC.
• · Related-party transactions noted including working capital loans and a services agreement with the Chief Financial Officer.
• · Restricted crypto asset periods (1 through 6) and staked Avalanche digital assets are disclosed as of March 31, 2026 and December 31, 2025.
• · Private placements occurred in 2025 with Astral Horizon LP (October 1, 2025) and Dragonfly Digital Management LLC (September 25, 2025).

10-07-2026

Apnimed, Inc. filed an S-1 registration statement for an IPO on the Nasdaq Global Market under the symbol 'APMD'. The company is a late-stage clinical pharmaceutical company focused on developing Oxnimbi for obstructive sleep apnea (OSA). While revenue from a related party surged to $84.8M in Q1 2026 from $3.1M a year earlier, the company has a history of significant net losses, including a $128.2M net loss for FY2025, and expects to continue incurring losses as it seeks FDA approval and commercial launch.

• · The company has no approved products and has never generated commercial revenue.
• · As of March 31, 2026, total liabilities ($137.2M) exceeded total assets ($79.0M), resulting in a stockholders' deficit of $304.1M.
• · The company had $46.9M in cash and cash equivalents as of March 31, 2026.
• · The offering includes an option for underwriters to purchase additional shares.
• · Proceeds will primarily fund regulatory approval and potential commercial launch of Oxnimbi for OSA, with remaining funds for R&D and working capital.

10-07-2026

Decoy Therapeutics Inc. (formerly Salarius Pharmaceuticals, Inc.) filed an S-1 registration statement on July 10, 2026, to register the resale of up to 3,766,500 shares of common stock by selling stockholders. The shares are issuable upon exercise of warrants issued in a private placement that closed on June 29, 2026, which raised approximately $3.5 million in upfront gross proceeds. The company is a pre-clinical stage biotechnology firm with no approved products or revenue from product sales, and its stock trades on Nasdaq under the symbol DCOY.

• · The company has no approved products for commercial sale and has not generated any revenue from product sales.
• · The S-1 is filed to fulfill contractual obligations to selling stockholders; the company will not receive proceeds from resales but will receive proceeds from any cash exercise of the warrants.
• · The private placement closed on June 29, 2026, with a single healthcare-focused institutional and accredited investor.
• · The company's common stock is listed on Nasdaq under the symbol DCOY; last reported sale price on July 8, 2026 was $5.75 per share.
• · The company effected a 1-for-15 reverse stock split on August 15, 2025, and a 1-for-12 reverse stock split on March 6, 2026.
• · The company is a smaller reporting company and has elected to comply with reduced public company reporting requirements.

10-07-2026

Universal Safety Products, Inc. (UUU) filed an S-1 registration statement with the SEC on July 10, 2026, for the resale of common stock by a selling stockholder. The company has a recent history of issuing convertible notes to SJC, including a June 2026 Securities Purchase Agreement for up to $10.6 million in principal (purchase price $10.0 million) across 11 tranches, with the first tranche of $1.06 million already closed. The filing incorporates by reference its FY2026 Annual Report and other recent SEC filings, and estimates total offering expenses at $40,665.

• · The S-1 registers the resale of common stock by a selling stockholder, not a primary offering by the company.
• · The June 2026 Securities Purchase Agreement with SJC requires stockholder and NYSE American approval for certain tranches.
• · Conversion price is the greater of $1.00 (floor) or 80% of the lowest VWAP over the prior five trading days, capped at $10.00 per share.
• · The company's Annual Report on Form 10-K for FY2026 was filed on July 2, 2026, and is incorporated by reference.
• · The company's website is www.universalsafetyprod.com; information on the website is not part of the prospectus.

10-07-2026

iPower Inc. filed an S-1 registration statement with the SEC on July 10, 2026, for a proposed offering of common stock. The filing details a new Digital Treasury Strategy involving investments in bitcoin (BTC) and ethereum (ETH), funded primarily through equity and debt financings. The company warns of significant risks, including the high volatility of digital assets (BTC traded between $57,725 and $126,279 in the prior 12 months), potential dilution from future equity offerings, and the untested nature of its digital asset strategy.

• · The company has never paid dividends on its capital stock and does not anticipate paying dividends in the foreseeable future.
• · The company intends to adopt ASU 2023-08 for digital asset holdings, which will require fair value measurement and recognition of gains/losses in net income each reporting period.
• · The company warns that its Digital Treasury Strategy has not been tested over an extended period or under different market conditions.
• · The company highlights counterparty risks related to custodians and the broader digital assets industry, including recent bankruptcies and regulatory enforcement actions.
• · The company notes that its ability to convert Series A Convertible Notes depends on future cash flow, and failure to do so could require asset sales, refinancing, or dilutive equity capital.

10-07-2026

Healthcare Triangle, Inc. (HCTI) filed an S-1 registration statement with the SEC on July 10, 2026, for a proposed initial public offering. The company is a healthcare IT firm offering cloud services, data science, and managed services, with proprietary platforms CloudEz, DataEz, Readabl.AI, Ziloy, and Ezovion. In January 2026, it acquired Teyame Holdings Inc. and its Spanish subsidiaries to add AI-powered omnichannel capabilities. The filing highlights a large addressable market but notes that recurring SaaS revenue from newer offerings is not yet material.

• · Company formed October 29, 2019 as a Nevada corporation, converted to Delaware on April 24, 2020.
• · Business commenced January 1, 2020 after SecureKloud Technologies Inc transferred its Life Sciences business.
• · Acquired Teyame Holdings Inc in January 2026, which owns Teyame 360 S.L. and Datono Mediación S.L. (Spain).
• · US healthcare cloud transformation services market expected to grow to $35.8B by 2034 (11.5% CAGR).
• · Global healthcare data science and analytics market estimated at $266.03B by 2034 (25.6% CAGR).
• · US healthcare IT services market estimated at $388.99B by 2030 (15.46% CAGR).
• · AI in healthcare market valued at $317.1B in 2032 (37.1% CAGR).
• · Recurring SaaS subscription revenue from Readabl.AI and Ezovion is not yet material to revenue growth.

10-07-2026

Holtec Nuclear Corp filed an S-1 registration statement for an IPO on July 10, 2026. For the three months ended March 31, 2026, total revenue was $165.3M, down 7.0% from $177.7M in the prior-year period. The NPD segment generated $80.5M gross operating profit, but the Palisades segment reported a $23.7M operating loss. Net income was $17.8M, supported by a $132.9M realized gain on investments, partially offset by a $198.2M unrealized loss. The company had $1.5B in remaining performance obligations as of March 31, 2026.

• · Palisades segment had no revenue in Q1 2026 or Q1 2025, and incurred $23.8M in operating expenses, resulting in a $23.7M loss before income taxes.
• · Accounts receivable decreased 24.9% from $130.8M at Dec 31, 2025 to $98.3M at Mar 31, 2026.
• · Inventories decreased 26.9% from $26.6M to $19.5M, driven by declines in raw materials and finished goods.
• · Depreciation expense surged from $2.5M in Q1 2025 to $26.7M in Q1 2026, a 968% increase, largely due to Palisades restart work in process being placed into service.
• · The company recorded a $132.9M realized gain on investments and a $198.2M unrealized loss on investments in Q1 2026.
• · Asset retirement obligation decreased 5.2% from $1.80B to $1.71B, driven by $54.2M in settlement gains and $12.0M in measurement gains.
• · The company expects to recognize 17% of its $1.5B remaining performance obligations within 12 months and 83% thereafter, mostly over three years.
• · No allowance for credit losses on accounts receivable was recorded as of March 31, 2026 or December 31, 2025.
• · The company has a $645.0M net long-term receivable from the DOE for spent fuel management, net of a $428.3M allowance for cost adjustments.

10-07-2026

Corvex, Inc. (formerly Movano Inc.) filed an S-1 registration statement on July 10, 2026, registering up to 53,390,008 shares of common stock for resale by selling stockholders, including shares issuable upon conversion of Series D Preferred Stock. The company recently completed a reverse merger with Corvex Legacy Holdings, Inc. on March 19, 2026, pivoting from its legacy health-tech business to an AI computing platform focused on GPU-accelerated infrastructure. The offering represents a massive potential overhang—94% of current outstanding shares—which could significantly depress the stock price, and the company will not receive any proceeds from the resale.

• · The company changed its name from Movano Inc. to Corvex, Inc. on April 2, 2019, and prior to that from Maestro Sensors Inc. on March 15, 2018.
• · The merger with Corvex Legacy Holdings closed on March 19, 2026, and the company issued Series B, C, and D Preferred Stock to prior securityholders.
• · A 2026 Stock Dividend of 0.358 shares per common share was distributed on April 6, 2026 to holders of record as of March 30, 2026.
• · The company will not receive any proceeds from the resale of shares by selling stockholders.
• · The company is an emerging growth company and expects to lose that status on December 31, 2026 (fifth anniversary of its initial S-1 effectiveness).
• · The company's legacy health-tech business (Movano) has been replaced by an AI computing platform focused on GPU-accelerated infrastructure.
• · The company's common stock trades on Nasdaq under symbol MOVE.

10-07-2026

Laser Photonics Corp filed a resale registration statement (S-1) covering up to approximately 11.8 million shares of common stock issued upon exercise of outstanding warrants by 14 selling stockholders, including funds managed by Intracoastal Capital, Iroquois Capital, Lind Global, Armistice Capital, and others. The company will not receive any proceeds from share sales by selling stockholders, though it may receive cash if warrants are exercised. This filing creates potential overhang on the stock price as a large block of shares becomes eligible for resale, and the company faces typical risks from securities litigation and ongoing business uncertainties.

• · The company will bear all registration, SEC filing, and blue sky compliance costs for this offering.
• · Selling stockholders with remaining beneficial ownership after the offering (Intracoastal, Iroquois entities, Boothbay) each hold less than 1% of outstanding shares.
• · Warrant exercise limitations prevent any selling stockholder from exceeding 4.99% or 9.99% beneficial ownership following exercise.
• · The company may use any cash proceeds from warrant exercises for inventory purchases, artist costs for upcoming festivals, transaction costs, expanded sales & marketing, partial prepayment of outstanding notes, and general working capital.
• · No dividends are expected in the foreseeable future.
• · The company faces risks of securities litigation, including class actions following significant business transactions, negative announcements, or periods of stock volatility.

10-07-2026

Tailored Brands, Inc. filed an S-1 registration statement with the SEC on July 10, 2026, for a proposed initial public offering. The filing includes extensive covenants and disclosure obligations typical of a credit agreement, but no specific financial results, offering size, or pricing details are provided. The document is a preliminary registration statement and does not contain any financial performance data.

• · The S-1 filing includes a detailed credit agreement with covenants regarding financial reporting, notices of material events, collateral information, and maintenance of existence, properties, and insurance.
• · The filing references a 'Holdco Guarantor' and 'Holdings' as parent entities, indicating a corporate structure with guarantees.
• · The registration statement does not disclose the number of shares to be offered, the expected price range, or any financial results.